Heme as a target for therapeutic interventions

Frontiers in Pharmacology

Volumn 8, Issue APR, 2017, Pages

  Immenschuh, Stephan ^a   Vijayan, Vijith ^a   Janciauskiene, Sabina ^a   Gueler, Faikah ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Heme; Heme oxygenases; Heme toxicity; Hemolysis; Hemopexin; Inflammation; Inflammatory diseases

Indexed keywords

HEME; HEME OXYGENASE; HEMOPEXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

BINDING AFFINITY; CIRCADIAN RHYTHM; ELECTRON TRANSPORT; ENDOTHELIUM CELL; HEMOLYTIC UREMIC SYNDROME; HOMEOSTASIS; HOMEOSTASIS AND REGULATION; HUMAN; LIPOPHILICITY; MALARIA; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; SEPSIS; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 85018744927     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00146     Document Type: Review

References (197)

1. Abraham, N. G., Cao, J., Sacerdoti, D., Li, X., and Drummond, G. (2009). Heme oxygenase: the key to renal function regulation. Am. J. Physiol. Renal Physiol. 297, F1137-F1152. doi: 10.1152/ajprenal.90449.2008
2. Abraham, N. G., Friedland, M. L., and Lever, R. (1983). "Heme metabolism in hepatic and erythroid cells," in Progress in Hematology, ed E. Brown (New York: Grune and Stratton), 75-130
3. Abraham, N. G., and Kappas, A. (2005). Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med. 39, 1-25. doi: 10.1016/j.freeradbiomed.2005.03.010
4. Abraham, N. G., and Kappas, A. (2008). Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 60, 79-127. doi: 10.1124/pr.107.07104
5. Abraham, N. G., Lin, J. H., Schwartzman, M. L., Levere, R. D., and Shibahara, S. (1988). The physiological significance of heme oxygenase. Int. J. Biochem. 20, 543-558. doi: 10.1016/0020-711X(88)90093-6
6. Adams, P. A., and Berman, M. C. (1980). Kinetics and mechanism of the interaction between human serum albumin and monomeric haemin. Biochem. J. 191, 95-102. doi: 10.1042/bj1910095
7. Aft, R. L., and Mueller, G. C. (1984). Hemin-mediated oxidative degradation of proteins. J. Biol. Chem. 259, 301-305
8. Aft, R. L., and Mueller, G. C. (1983). Hemin-mediated DNA strand scission. J. Biol. Chem. 258, 12069-12072
9. Aggarwal, S., Lam, A., Bolisetty, S., Carlisle, M. A., Traylor, A., Agarwal, A., et al. (2016). Heme attenuation ameliorates irritant gas inhalation-induced acute lung injury. Antioxid. Redox Signal. 24, 99-112. doi: 10.1089/ars.2015.6347
10. Allhorn, M., Berggard, T., Nordberg, J., Olsson, M. L., and Akerstrom, B. (2002). Processing of the lipocalin a1-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood 99, 1894-1901. doi: 10.1182/blood.V99.6.1894
11. Alvarado, G., Jeney, V., Toth, A., Csosz, E., Kallo, G., Huynh, A. T., et al. (2015). Heme-induced contractile dysfunction in human cardiomyocytes caused by oxidant damage to thick filament proteins. Free Radic. Biol. Med. 89, 248-262. doi: 10.1016/j.freeradbiomed.2015.07.158
12. Andrade, B. B., Araujo-Santos, T., Luz, N. F., Khouri, R., Bozza, M. T., Camargo, L. M., et al. (2010). Heme impairs prostaglandin E2 and TGF-β production by human mononuclear cells via Cu/Zn superoxide dismutase: insight into the pathogenesis of severe malaria. J. Immunol. 185, 1196-1204. doi: 10.4049/jimmunol.0904179
13. Angus, D. C., and van der Poll, T. (2013). Severe sepsis and septic shock. N. Engl. J. Med. 369, 840-851. doi: 10.1056/NEJMra1208623
14. Baek, J. H., D'Agnillo, F., Vallelian, F., Pereira, C. P., Williams, M. C., Jia, Y., et al. (2012). Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J. Clin. Invest. 122, 1444-1458. doi: 10.1172/JCI59770
15. Bakker, W. W., Borghuis, T., Harmsen, M. C. A., Van den Berg, A., Kema, I. P., Niezen, K. E., et al. (2005). Protease activity of plasma hemopexin. Kidney Int. 68, 603-610. doi: 10.1111/j.1523-1755.2005.00438.x
16. Balla, G., Jacob, H. S., Balla, J., Rosenberg, M., Nath, K., Apple, F., et al. (1992). Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267, 18148-18153
17. Balla, G., Vercellotti, G. M., Muller-Eberhard, U., Eaton, J., and Jacob, H. S. (1991). Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab. Invest. 64, 648-655
18. Balla, J., Jacob, H. S., Balla, G., Nath, K., Eaton, J. W., and Vercellotti, G. (1993). Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. U.S.A. 90, 9285-9289. doi: 10.1073/pnas.90.20.9285
19. Balogun, E., Hoque, M., Gong, P., Killeen, E., Green, C. J., Foresti, R., et al. (2003). Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 371, 887-895. doi: 10.1042/bj20021619
20. Baumann, H., and Gauldie, J. (1994). The acute phase response. Immunol. Today 15, 74-80. doi: 10.1016/0167-5699(94)90137-6
21. Bean, C. J., Boulet, S. L., Ellingsen, D., Pyle, M. E., Barron-Casella, E. A., Casella, J. F., et al. (2012). Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood 120, 3822-3828. doi: 10.1182/blood-2011-06-361642
22. Belcher, J. D., Bryant, C. J., Nguyen, J., Bowlin, P. R., Kielbik, M. C., Bischof, J. C., et al. (2003). Transgenic sickle mice have vascular inflammation. Blood 101, 3953-3959. doi: 10.1182/blood-2002-10-3313
23. Belcher, J. D., Chen, C., Nguyen, J., Milbauer, L., Abdulla, F., Alayash, A. I., et al. (2014). Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 123, 377-390. doi: 10.1182/blood-2013-04-495887
24. Belcher, J. D., Chen, C., Nguyen, J., Zhang, P., Abdulla, F., Nguyen, P., et al. (2016). Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate. Antioxid. Redox Signal. doi: 10.1089/ars.2015.6571. [Epub ahead of print]
25. Belcher, J. D., Mahaseth, H., Welch, T. E., Otterbein, L. E., Hebbel, R. P., and Vercellotti, G. M. (2006). Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J. Clin. Invest. 116, 808-816. doi: 10.1172/JCI26857
26. Belcher, J. D., Vineyard, J. V., Bruzzone, C. M., Chen, C., Beckman, J. D., Nguyen, J., et al. (2010). Heme oxygenase-1 gene delivery by sleeping beauty inhibits vascular stasis in a murine model of sickle cell disease. J. Mol. Med. (Berl.) 88, 665-675. doi: 10.1007/s00109-010-0613-6
27. Bissell, D. M., Hammaker, L., and Schmid, R. (1972). Hemoglobin and erythrocyte catabolism in rat liver: the separate roles of parenchymal and sinusoidal cells. Blood 40, 812-822
28. Bolisetty, S., Zarjou, A., Hull, T. D., Traylor, A. M., Perianayagam, A., Joseph, R., et al. (2015). Macrophage and epithelial cell H-ferritin expression regulates renal inflammation. Kidney Int. 88, 95-108. doi: 10.1038/ki.2015.102
29. Bone, R. C. (1991). Let's agree on terminology: definitions of sepsis. Crit. Care Med. 19, 973-976. doi: 10.1097/00003246-199107000-00024
30. Bonkowsky, H. L., Tschudy, D. P., Collins, A., Doherty, J., Bossenmaier, I., Cardinal, R., et al. (1971). Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc. Natl. Acad. Sci. U.S.A. 68, 2725-2729. doi: 10.1073/pnas.68.11.2725
31. Bunn, H. F., and Jandl, J. H. (1968). Exchange of heme among hemoglobins and between hemoglobin and albumin. J. Biol. Chem. 243, 465-475
32. Burris, T. P. (2008). Nuclear hormone receptors for heme: REV-ERBa and REV-ERBβ are ligand-regulated components of the mammalian clock. Mol. Endocrinol. 22, 1509-1520. doi: 10.1210/me.2007-0519
33. Calay, D., and Mason, J. C. (2014). The multifunctional role and therapeutic potential of HO-1 in the vascular endothelium. Antioxid. Redox Signal. 20, 1789-1809. doi: 10.1089/ars.2013.5659
34. Camus, S. M., De Moraes, J. A., Bonnin, P., Abbyad, P., Le Jeune, S., Lionnet, F., et al. (2015). Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. Blood 125, 3805-3814. doi: 10.1182/blood-2014-07-589283
35. Cao, J., Peterson, S. J., Sodhi, K., Vanella, L., Barbagallo, I., Rodella, L. F., et al. (2012). Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet. Hypertension 60, 467-475. doi: 10.1161/HYPERTENSIONAHA.112.193805
36. Cao, J., Sodhi, K., Inoue, K., Quilley, J., Rezzani, R., Rodella, L., et al. (2011). Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Hum. Gene Ther. 22, 271-282. doi: 10.1089/hum.2010.059
37. Chakravarti, R., Aulak, K. S., Fox, P. L., and Stuehr, D. J. (2010). GAPDH regulates cellular heme insertion into inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 107, 18004-18009. doi: 10.1073/pnas.1008133107
38. Chance, B. (1967). The reactivity of haemoproteins and cytochromes. Biochem. J. 103, 1-18. doi: 10.1042/bj1030001
39. Chauveau, C., Bouchet, D., Roussel, J. C., Mathieu, P., Braudeau, C., Renaudin, K., et al. (2002). Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am. J. Transplant. 2, 581-592. doi: 10.1034/j.1600-6143.2002.20702.x
40. Chen, G., Zhang, D., Fuchs, T. A., Manwani, D., Wagner, D. D., and Frenette, P. S. (2014). Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. Blood 123, 3818-3827. doi: 10.1182/blood-2013-10-529982
41. Cheung, P. K., Stulp, B., Immenschuh, S., Borghuis, T., Baller, J. F., and Bakker, W. (1999). Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J. Am. Soc. Nephrol. 10, 1700-1708
42. Chiabrando, D., Vinchi, F., Fiorito, V., Mercurio, S., and Tolosano, E. (2014). Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front. Pharmacol. 5:61. doi: 10.3389/fphar.2014.00061
43. Deuel, J. W., Vallelian, F., Schaer, C. A., Puglia, M., Buehler, P. W., and Schaer, D. J. (2015). Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity. Free Radic. Biol. Med. 89, 931-943. doi: 10.1016/j.freeradbiomed.2015.09.016
44. Devadas, K., and Dhawan, S. (2006). Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction. J. Immunol. 176, 4252-4257. doi: 10.4049/jimmunol.176.7.4252
45. Doberer, D., Haschemi, A., Andreas, M., Zapf, T. C., Clive, B., Jeitler, M., et al. (2010). Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects. Br. J. Pharmacol. 161, 1751-1762. doi: 10.1111/j.1476-5381.2010.00990.x
46. Dorresteijn, M. J., Paine, A., Zilian, E., Fenten, M. G., Frenzel, E., Janciauskiene, S., et al. (2015). Cell-type-specific downregulation of heme oxygenase-1 by lipopolysaccharide via Bach1 in primary human mononuclear cells. Free Radic. Biol. Med. 78, 224-232. doi: 10.1016/j.freeradbiomed.2014.10.579
47. Dutra, F. F., Alves, L. S., Rodrigues, D., Fernandez, P. L., de Oliveira, R. B., Golenbock, D. T., et al. (2014). Hemolysis-induced lethality involves inflammasome activation by heme. Proc. Natl. Acad. Sci. U.S.A. 111, E4110-E4118. doi: 10.1073/pnas.1405023111
48. Dutra, F. F., and Bozza, M. T. (2014). Heme on innate immunity and inflammation. Front. Pharmacol. 5:115. doi: 10.3389/fphar.2014.00115
49. Elphinstone, R. E., Conroy, A. L., Hawkes, M., Hermann, L., Namasopo, S., Warren, H. S., et al. (2016). Alterations in systemic extracellular heme and hemopexin are associated with adverse clinical outcomes in Ugandan children with severe malaria. J. Infect. Dis. 214, 1268-1275. doi: 10.1093/infdis/jiw357
50. Exner, M., Minar, E., Wagner, O., and Schillinger, M. (2004). The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic. Biol. Med. 37, 1097-1104. doi: 10.1016/j.freeradbiomed.2004.07.008
51. Figueiredo, R. T., Fernandez, P. L., Mourao-Sa, D. S., Porto, B. N., Dutra, F. F., Alves, L. S., et al. (2007). Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282, 20221-20229. doi: 10.1074/jbc.M610737200
52. Frimat, M., Tabarin, F., Dimitrov, J. D., Poitou, C., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V. T., et al. (2013). Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome. Blood 122, 282-292. doi: 10.1182/blood-2013-03-489245
53. Ghosh, S., Adisa, O. A., Chappa, P., Tan, F., Jackson, K. A., Archer, D. R. Ofori-Acquah, et al. (2013). Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J. Clin. Invest. 123, 4809-4820. doi: 10.1172/JCI64578
54. Girvan, H. M., and Munro, A. W. (2013). Heme sensor proteins. J. Biol. Chem. 288, 13194-13203. doi: 10.1074/jbc.R112.422642
55. Glueck, R., Green, D., Cohen, I., and Ts'ao, C. H. (1983). Hematin: unique effects of hemostasis. Blood 61, 243-249
56. Goetsch, C. A., and Bissell, D. M. (1986). Instability of hematin used in the treatment of acute hepatic porphyria. N. Engl. J. Med. 315, 235-238. doi: 10.1056/NEJM198607243150406
57. Gotts, J. E., and Matthay, M. A. (2016). Sepsis: pathophysiology and clinical management. BMJ 353:i1585. doi: 10.1136/bmj.i1585
58. Gozzelino, R., Jeney, V., and Soares, M. P. (2010). Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 50, 323-354. doi: 10.1146/annurev.pharmtox.010909.105600
59. Gram, M., Sveinsdottir, S., Cinthio, M., Sveinsdottir, K., Hansson, S. R., Morgelin, M., et al. (2014). Extracellular hemoglobin-mediator of inflammation and cell death in the choroid plexus following preterm intraventricular hemorrhage. J. Neuroinflammation 11:200. doi: 10.1186/s12974-014-0200-9
60. Granick, S., Sinclair, P., Sassa, S., and Grieninger, G. (1975). Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. J. Biol. Chem. 250, 9215-9225
61. Graw, J. A., Mayeur, C., Rosales, I., Liu, Y., Sabbisetti, V. S., Riley, F. E., et al. (2016). Haptoglobin or hemopexin therapy prevents acute adverse effects of resuscitation after prolonged storage of red cells. Circulation 134, 945-960. doi: 10.1161/CIRCULATIONAHA.115.019955
62. Greil, J., Verga-Falzacappa, M. V., Echner, N. E., Behnisch, W., Bandapalli, O. R., Pechanska, P., et al. (2016). Mutating heme oxygenase-1 into a peroxidase causes a defect in bilirubin synthesis associated with microcytic anemia and severe hyperinflammation. Haematologica 101, e436-e439. doi: 10.3324/haematol.2016.147090
63. Griffiths, E., Cortes, A., Gilbert, N., Stevenson, P., MacDonald, S., and Pepper, D. (1995). Haemoglobin-based blood substitutes and sepsis. Lancet 345, 158-160. doi: 10.1016/S0140-6736(95)90168-X
64. Grosser, N., Hemmerle, A., Berndt, G., Erdmann, K., Hinkelmann, U., Schurger, S., et al. (2004). The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic. Biol. Med. 37, 2064-2071. doi: 10.1016/j.freeradbiomed.2004.09.009
65. Hada, H., Shiraki, T., Watanabe-Matsui, M., and Igarashi, K. (2014). Hemopexin-dependent heme uptake via endocytosis regulates the Bach1 transcription repressor and heme oxygenase gene activation. Biochim. Biophys. Acta 1840, 2351-2360. doi: 10.1016/j.bbagen.2014.02.029
66. Haldar, M., Kohyama, M., So, A. Y., Kc, W., Wu, X., Briseno, C. G., et al. (2014). Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell 156, 1223-1234. doi: 10.1016/j.cell.2014.01.069
67. Hamza, I., and Dailey, H. A. (2012). One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans. Biochim. Biophys. Acta 1823, 1617-1632. doi: 10.1016/j.bbamcr.2012.04.009
68. Harvey, J. W., and Beutler, E. (1982). Binding of heme by glutathione S-transferase: a possible role of the erythrocyte enzyme. Blood 60, 1227-1230
69. Hebbel, R. P., Morgan, W. T., Eaton, J. W., and Hedlund, B. E. (1988). Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc. Natl. Acad. Sci. U.S.A. 85, 237-241. doi: 10.1073/pnas.85.1.237
70. Heinrich, P. C., Castell, J. V., and Andus, T. (1990). Interleukin-6 and the acute phase response. Biochem. J. 265, 621-636. doi: 10.1042/bj2650621
71. Horvath, K., Varga, C., Berko, A., Posa, A., Laszlo, F., and Whittle, B. J. (2008). The involvement of heme oxygenase-1 activity in the therapeutic actions of 5-aminosalicylic acid in rat colitis. Eur. J. Pharmacol. 581, 315-323. doi: 10.1016/j.ejphar.2007.12.004
72. Hvidberg, V., Maniecki, M. B., Jacobsen, C., Hojrup, P., Moller, H. J., and Moestrup, S. K. (2005). Identification of the receptor scavenging hemopexin-heme complexes. Blood 106, 2572-2579. doi: 10.1182/blood-2005-03-1185
73. Immenschuh, S., Baumgart-Vogt, E., Tan, M., Iwahara, S., Ramadori, G., and Fahimi, H. D. (2003). Differential cellular and subcellular localization of heme-binding protein 23/peroxiredoxin I and heme oxygenase-1 in rat liver. J. Histochem. Cytochem. 51, 1621-1631. doi: 10.1177/002215540305101206
74. Immenschuh, S., Hinke, V., Ohlmann, A., Gifhorn-Katz, S., Katz, N., Jungermann, K., et al. (1998a). Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes. Biochem. J. 334(Pt 1), 141-146. doi: 10.1042/bj3340141
75. Immenschuh, S., Kietzmann, T., Hinke, V., Wiederhold, M., Katz, N., and Muller-Eberhard, U. (1998b). The rat heme oxygenase-1 gene is transcriptionally induced via the protein kinase A signaling pathway in rat hepatocyte cultures. Mol. Pharmacol. 53, 483-491
76. Immenschuh, S., Nagae, Y., Satoh, H., Baumann, H., and Muller-Eberhard, U. (1994). The rat and human hemopexin genes contain an identical interleukin-6 response element that is not a target of CAAT enhancer-binding protein isoforms. J. Biol. Chem. 269, 12654-12661
77. Immenschuh, S., and Ramadori, G. (2000). Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem. Pharmacol. 60, 1121-1128. doi: 10.1016/S0006-2952(00)00443-3
78. Immenschuh, S., Tan, M., and Ramadori, G. (1999). Nitric oxide mediates the lipopolysaccharide dependent upregulation of the heme oxygenase-1 gene expression in cultured rat Kupffer cells. J. Hepatol. 30, 61-69. doi: 10.1016/S0168-8278(99)80008-7
79. Ingram, V. M. (1957). Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 180, 326-328. doi: 10.1038/180326a0
80. Iwahara, S., Satoh, H., Song, D. X., Webb, J., Burlingame, A. L., Nagae, Y., et al. (1995). Purification, characterization and cloning of a heme-binding protein (23kDa) in rat liver cytosol. Biochemistry 34, 13398-13406. doi: 10.1021/bi00041a017
81. Janz, D. R., Bastarache, J. A., Sills, G., Wickersham, N., May, A. K., Bernard, G. R., et al. (2013). Association between haptoglobin, hemopexin and mortality in adults with sepsis. Crit. Care 17:R272. doi: 10.1186/cc13108
82. Jeney, V., Balla, G., and Balla, J. (2014). Red blood cell, hemoglobin and heme in the progression of atherosclerosis. Front. Physiol. 5:379. doi: 10.3389/fphys.2014.00379
83. Jeney, V., Balla, J., Yachie, A., Varga, Z., Vercellotti, G. M., Eaton, J. W., et al. (2002). Pro-oxidant and cytotoxic effects of circulating heme. Blood 100, 879-887. doi: 10.1182/blood.V100.3.879
84. Kapturczak, M. H., Wasserfall, C., Brusko, T., Campbell-Thompson, M., Ellis, T. M., Atkinson, M. A., et al. (2004). Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 165, 1045-1053. doi: 10.1016/S0002-9440(10)63365-2
85. Karnaukhova, E., Krupnikova, S. S., Rajabi, M., and Alayash, A. I. (2012). Heme binding to human alpha-1 proteinase inhibitor. Biochim. Biophys. Acta 1820, 2020-2029. doi: 10.1016/j.bbagen.2012.09.012
86. Keleku-Lukwete, N., Suzuki, M., Otsuki, A., Tsuchida, K., Katayama, S., Hayashi, M., et al. (2015). Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation. Proc. Natl. Acad. Sci. U.S.A. 112, 12169-12174. doi: 10.1073/pnas.1509158112
87. Khechaduri, A., Bayeva, M., Chang, H. C., and Ardehali, H. (2013). Heme levels are increased in human failing hearts. J. Am. Coll. Cardiol. 61, 1884-1893. doi: 10.1016/j.jacc.2013.02.012
88. Kordac, V., Kozakova, M., and Martasek, P. (1989). Changes of myocardial functions in acute hepatic porphyrias. Role of heme arginate administration. Ann. Med. 21, 273-276. doi: 10.3109/07853898909149205
89. Kovtunovych, G., Eckhaus, M. A., Ghosh, M. C., Ollivierre-Wilson, H., and Rouault, T. A. (2010). Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 116, 6054-6062. doi: 10.1182/blood-2010-03-272138
90. Kumar, S., and Bandyopadhyay, U. (2005). Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157, 175-188. doi: 10.1016/j.toxlet.2005.03.004
91. Kutty, R. K., and Maines, M. D. (1981). Purification and characterization of biliverdin reductase from rat liver. J. Biol. Chem. 256, 3956-3962
92. Larsen, R., Gouveia, Z., Soares, M. P., and Gozzelino, R. (2012). Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases. Front. Pharmacol. 3:77. doi: 10.3389/fphar.2012.00077
93. Larsen, R., Gozzelino, R., Jeney, V., Tokaji, L., Bozza, F. A., Japiassu, A. M., et al. (2010). A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2:51ra71. doi: 10.1126/scitranslmed.3001118
94. Lee, T. S., Chang, C. C., Zhu, Y., and Shyy, J. Y. (2004). Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110, 1296-1302. doi: 10.1161/01.CIR.0000140694.67251.9C
95. Lelubre, C., Piagnerelli, M., and Vincent, J. L. (2009). Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: myth or reality? Transfusion 49, 1384-1394. doi: 10.1111/j.1537-2995.2009.02211.x
96. Lever, J. M., Boddu, R., George, J. F., and Agarwal, A. (2016). Heme oxygenase-1 in kidney health and disease. Antioxid. Redox Signal. 25, 165-183. doi: 10.1089/ars.2016.6659
97. Levere, R. D., Gong, Y. F., Kappas, A., Bucher, D. J., Wormser, G. P., and Abraham, N. G. (1991). Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine. Proc. Natl. Acad. Sci. U.S.A. 88, 1756-1759. doi: 10.1073/pnas.88.5.1756
98. Li, C., Hossieny, P., Wu, B. J., Qawasmeh, A., Beck, K., and Stocker, R. (2007). Pharmacologic induction of heme oxygenase-1. Antioxid. Redox Signal. 9, 2227-2239. doi: 10.1089/ars.2007.1783
99. Liem, H. H., Noy, N., and Muller-Eberhard, U. (1994). Studies on the efflux of heme from biological membranes. Biochim. Biophys. Acta 1194, 264-270. doi: 10.1016/0005-2736(94)90308-5
100. Lin, T., Kwak, Y. H., Sammy, F., He, P., Thundivalappil, S., Sun, G., et al. (2010). Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J. Infect. Dis. 202, 624-632. doi: 10.1086/654929
101. Lin, T., Liu, J., Huang, F., Van Engelen, T. S., Thundivalappil, S. R., Riley, F. E., et al. (2016). Purified and recombinant hemopexin: protease activity and effect on neutrophil chemotaxis. Mol. Med. 22, 22-31. doi: 10.2119/molmed.2016.00006
102. Lin, T., Maita, D., Thundivalappil, S. R., Riley, F. E., Hambsch, J., Van Marter, L. J., et al. (2015). Hemopexin in severe inflammation and infection: mouse models and human diseases. Crit. Care 19:166. doi: 10.1186/s13054-015-0885-x
103. Little, H. N., and Neilands, J. B. (1960). Binding of haematin by human serum albumin. Nature 188, 913-915. doi: 10.1038/188913a0
104. Lundvig, D. M., Immenschuh, S., and Wagener, F. A. (2012). Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly? Front. Pharmacol. 3:81. doi: 10.3389/fphar.2012.00081
105. Ma, B., Day, J. P., Phillips, H., Slootsky, B., Tolosano, E., and Dore, S. (2016). Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage. J. Neuroinflammation 13:26. doi: 10.1186/s12974-016-0490-1
106. Maines, M. D. (1997). The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517-554. doi: 10.1146/annurev.pharmtox.37.1.517
107. Maines, M. D., and Kappas, A. (1974). Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc. Natl. Acad. Sci. U.S.A. 71, 4293-4297. doi: 10.1073/pnas.71.11.4293
108. Martin, D., Rojo, A. I., Salinas, M., Diaz, R., Gallardo, G., Alam, J., et al. (2004). Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J. Biol. Chem. 279, 8919-8929. doi: 10.1074/jbc.M309660200
109. Mendonca, V. R., Luz, N. F., Santos, N. J., Borges, V. M., Goncalves, M. S., Andrade, B. B., et al. (2012). Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infect. Immun. 80, 1445-1454. doi: 10.1128/IAI.05933-11
110. Mense, S. M., and Zhang, L. (2006). Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases. Cell Res. 16, 681-692. doi: 10.1038/sj.cr.7310086
111. Mestas, J., and Hughes, C. C. (2004). Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731-2738. doi: 10.4049/jimmunol.172.5.2731
112. Miller, L. H., Baruch, D. I., Marsh, K., and Doumbo, O. K. (2002). The pathogenic basis of malaria. Nature 415, 673-679. doi: 10.1038/415673a
113. Miyazaki, T., Kirino, Y., Takeno, M., Samukawa, S., Hama, M., Tanaka, M., et al. (2010). Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1. Cancer Sci. 101, 1409-1416. doi: 10.1111/j.1349-7006.2010.01550.x
114. Mosser, D. M., and Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969. doi: 10.1038/nri2448
115. Motterlini, R., and Foresti, R. (2014). Heme oxygenase-1 as a target for drug discovery. Antioxid. Redox Signal. 20, 1810-1826. doi: 10.1089/ars.2013.5658
116. Muller Eberhard, U. (1970). Hemopexin. N. Engl. J. Med. 283, 1090-1094. doi: 10.1056/NEJM197011122832007
117. Muller-Eberhard, U., and Cleve, H. (1963). Immunoelectrophoretic studies of the beta1-haem-binding globulin (haemopexin) in hereditary haemolytic disorders. Nature 197, 602-603. doi: 10.1038/197602a0
118. Muller-Eberhard, U., Javid, J., Liem, H. H., Hanstein, A., and Hanna, M. (1968). Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood 32, 811-815
119. Muller Eberhard, U., and Nikkilä, H. (1989). Transport of tetrapyrroles by proteins. Semin. Hematol. 26, 86-104
120. Mustajoki, P., Tenhunen, R., Tokola, O., and Gothoni, G. (1986). Haem arginate in the treatment of acute hepatic porphyrias. Br. Med. J. (Clin. Res. Ed.) 293, 538-539. doi: 10.1136/bmj.293.6546.538-a
121. Nagy, E., Eaton, J. W., Jeney, V., Soares, M. P., Varga, Z., Galajda, Z., et al. (2010). Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 30, 1347-1353. doi: 10.1161/ATVBAHA.110.206433
122. Nakamichi, I., Habtezion, A., Zhong, B., Contag, C. H., Butcher, E. C., and Omary, M. B. (2005). Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 induction. J. Clin. Invest. 115, 3007-3014. doi: 10.1172/JCI24912
123. Nath, K. A., Balla, G., Vercellotti, G. M., Balla, J., Jacob, H. S., Levitt, M. D., et al. (1992). Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J. Clin. Invest. 90, 267-270. doi: 10.1172/JCI115847
124. Nath, K. A., Balla, J., Croatt, A. J., and Vercellotti, G. M. (1995). Heme protein-mediated renal injury: a protective role for 21-aminosteroids in vitro and in vivo. Kidney Int. 47, 592-602. doi: 10.1038/ki.1995.75
125. Nath, K. A., and Katusic, Z. S. (2012). Vasculature and kidney complications in sickle cell disease. J. Am. Soc. Nephrol. 23, 781-784. doi: 10.1681/ASN.2011101019
126. Ndisang, J. F., Lane, N., and Jadhav, A. (2009). The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinology 150, 2098-2108. doi: 10.1210/en.2008-0239
127. Otterbein, L., Sylvester, S. L., and Choi, A. M. (1995). Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am. J. Respir. Cell Mol. Biol. 13, 595-601. doi: 10.1165/ajrcmb.13.5.7576696
128. Paine, A., Eiz-Vesper, B., Blasczyk, R., and Immenschuh, S. (2010). Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem. Pharmacol. 80, 1895-1903. doi: 10.1016/j.bcp.2010.07.014
129. Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S., et al. (2007). Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 13, 703-710. doi: 10.1038/nm1586
130. Paoli, M., Anderson, B. F., Baker, H. M., Morgan, W. T., Smith, A., Baker, E., et al. (1999). Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two β-propeller domains. Nat. Struct. Biol. 6, 926-931. doi: 10.1038/13294
131. Paul, G., Bataille, F., Obermeier, F., Bock, J., Klebl, F., Strauch, U., et al. (2005). Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin. Exp. Immunol. 140, 547-555. doi: 10.1111/j.1365-2249.2005.02775.x
132. Pechlaner, R., Willeit, P., Summerer, M., Santer, P., Egger, G., Kronenberg, F., et al. (2015). Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 35, 229-236. doi: 10.1161/ATVBAHA.114.304729
133. Petersen, B., Ramackers, W., Lucas-Hahn, A., Lemme, E., Hassel, P., Queisser, A. L., et al. (2011). Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys. Xenotransplantation 18, 355-368. doi: 10.1111/j.1399-3089.2011.00674.x
134. Peterson, S. J., Kim, D. H., Li, M., Positano, V., Vanella, L., Rodella, L. F., et al. (2009). The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J. Lipid Res. 50, 1293-1304. doi: 10.1194/jlr.M800610-JLR200
135. Pober, J. S., Min, W., and Bradley, J. R. (2009). Mechanisms of endothelial dysfunction, injury, and death. Annu. Rev. Pathol. 4, 71-95. doi: 10.1146/annurev.pathol.4.110807.092155
136. Poli, V., Mancini, F. P., and Cortese, R. (1990). IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63, 643-653. doi: 10.1016/0092-8674(90)90459-R
137. Ponka, P. (1997). Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89, 1-25
138. Ponka, P. (1999). Cell biology of heme. Am. J. Med. Sci. 318, 241-256. doi: 10.1016/S0002-9629(15)40628-7
139. Poss, K. D., Thomas, M. J., Ebralidze, A. K., O'Dell, T. J., and Tonegawa, S. (1995). Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice. Neuron 15, 867-873. doi: 10.1016/0896-6273(95)90177-9
140. Poss, K. D., and Tonegawa, S. (1997a). Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. U.S.A. 94, 10925-10930. doi: 10.1073/pnas.94.20.10925
141. Poss, K. D., and Tonegawa, S. (1997b). Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U.S.A. 94, 10919-10924. doi: 10.1073/pnas.94.20.10919
142. Potter, D., Chroneos, Z. C., Baynes, J. W., Sinclair, P. R., Gorman, N., Liem, H. H., et al. (1993). In vivo fate of hemopexin and heme-hemopexin complexes in the rat. Arch. Biochem. Biophys. 300, 98-104. doi: 10.1006/abbi.1993.1014
143. Reeder, B. J. (2010). The redox activity of hemoglobins: from physiologic functions to pathologic mechanisms. Antioxid. Redox Signal. 13, 1087-1123. doi: 10.1089/ars.2009.2974
144. Rifkind, J. M., and Nagababu, E. (2013). Hemoglobin redox reactions and red blood cell aging. Antioxid. Redox Signal. 18, 2274-2283. doi: 10.1089/ars.2012.4867
145. Roumenina, L. T., Rayes, J., Lacroix-Desmazes, S., and Dimitrov, J. D. (2016). Heme: modulator of plasma systems in hemolytic diseases. Trends Mol. Med. 22, 200-213. doi: 10.1016/j.molmed.2016.01.004
146. Ryter, S. W., Alam, J., and Choi, A. M. (2006). Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650. doi: 10.1152/physrev.00011.2005
147. Ryter, S. W., and Tyrrell, R. M. (2000). The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro-and antioxidant properties. Free Radic. Biol. Med. 28, 289-309. doi: 10.1016/S0891-5849(99)00223-3
148. Sadrzadeh, S. M., Anderson, D. K., Panter, S. S., Hallaway, P. E., and Eaton, J. W. (1987). Hemoglobin potentiates central nervous system damage. J. Clin. Invest. 79, 662-664. doi: 10.1172/JCI112865
149. Saragih, H., Zilian, E., Jaimes, Y., Paine, A., Figueiredo, C., Eiz-Vesper, B., et al. (2014). PECAM-1-dependent heme oxygenase-1 regulation via an Nrf2-mediated pathway in endothelial cells. Thromb. Haemost. 111, 1077-1088. doi: 10.1160/TH13-11-0923
150. Satoh, T., Satoh, H., Iwahara, S., Hrkal, Z., Peyton, D. H., and Muller-Eberhard, U. (1994). Roles of heme iron-coordinating histidine residues of human hemopexin expressed in baculovirus-infected insect cells. Proc. Natl. Acad. Sci. U.S.A. 91, 8423-8427. doi: 10.1073/pnas.91.18.8423
151. Sawicki, K. T., Shang, M., Wu, R., Chang, H. C., Khechaduri, A., Sato, T., et al. (2015). Increased Heme Levels in the Heart Lead to Exacerbated Ischemic Injury. J. Am. Heart Assoc. 4:e002272. doi: 10.1161/JAHA.115.002272
152. Schaedler, R. W., and Dubos, R. J. (1961). The susceptibility of mice to bacterial endotoxins. J. Exp. Med. 113, 559-570. doi: 10.1084/jem.113.3.559
153. Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., and Vercellotti, G. M. (2012). Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood 121, 1276-1284. doi: 10.1182/blood-2012-11-451229
154. Schaer, D. J., Vinchi, F., Ingoglia, G., Tolosano, E., and Buehler, P. W. (2014). Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front. Physiol. 5:415. doi: 10.3389/fphys.2014.00415
155. Seixas, E., Gozzelino, R., Chora, A., Ferreira, A., Silva, G., Larsen, R., et al. (2009). Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc. Natl. Acad. Sci. U.S.A. 106, 15837-15842. doi: 10.1073/pnas.0903419106
156. Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., et al. (2013). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U.S.A. 110, 3507-3512. doi: 10.1073/pnas.1222878110
157. Shen, Y., Ward, N. C., Hodgson, J. M., Puddey, I. B., Wang, Y., Zhang, D., et al. (2013). Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1. Free Radic. Biol. Med. 65, 908-915. doi: 10.1016/j.freeradbiomed.2013.08.185
158. Sikorski, E. M., Hock, T., Hill-Kapturczak, N., and Agarwal, A. (2004). The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury. Am. J. Physiol. Renal Physiol. 286, F425-F441. doi: 10.1152/ajprenal.00297.2003
159. Simionatto, C. S., Cabal, R., Jones, R. L., and Galbraith, R. A. (1988). Thrombophlebitis and disturbed hemostasis following administration of intravenous hematin in normal volunteers. Am. J. Med. 85, 538-540. doi: 10.1016/S0002-9343(88)80092-5
160. Smith, A., and McCulloh, R. J. (2015). Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front. Physiol. 6:187. doi: 10.3389/fphys.2015.00187
161. Soares, M. P., and Bozza, M. T. (2016). Red alert: labile heme is an alarmin. Curr. Opin. Immunol. 38, 94-100. doi: 10.1016/j.coi.2015.11.006
162. Solar, I., Muller-Eberhard, U., Shviro, Y., and Shaklai, N. (1991). Long-term intercalation of residual hemin in erythrocyte membranes distorts the cell. Biochim. Biophys. Acta 1062, 51-58. doi: 10.1016/0005-2736(91)90334-5
163. Son, Y., Lee, J. H., Chung, H. T., and Pae, H. O. (2013). Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1. Oxid. Med. Cell Longev. 2013:639541. doi: 10.1155/2013/639541
164. Spiller, F., Costa, C., Souto, F. O., Vinchi, F., Mestriner, F. L., Laure, H. J., et al. (2011). Inhibition of neutrophil migration by hemopexin leads to increased mortality due to sepsis in mice. Am. J. Respir. Crit. Care Med. 183, 922-931. doi: 10.1164/rccm.201002-0223OC
165. Stapley, R., Rodriguez, C., Oh, J. Y., Honavar, J., Brandon, A., Wagener, B. M., et al. (2015). Red blood cell washing, nitrite therapy, and antiheme therapies prevent stored red blood cell toxicity after trauma-hemorrhage. Free Radic. Biol. Med. 85, 207-218. doi: 10.1016/j.freeradbiomed.2015.04.025
166. Taketani, S., Adachi, Y., Kohno, H., Ikehara, S., Tokunaga, R., and Ishii, T. (1998). Molecular characterization of a newly identified heme-binding protein induced during differentiation of murine erythroleukemia cells. J. Biol. Chem. 273, 31388-31394. doi: 10.1074/jbc.273.47.31388
167. Tenhunen, R., Marver, H. S., and Schmid, R. (1968). The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A. 61, 748-755. doi: 10.1073/pnas.61.2.748
168. Thomas, R. A., Czopek, A., Bellamy, C. O., McNally, S. J., Kluth, D. C., and Marson, L. P. (2016). Hemin preconditioning upregulates heme oxygenase-1 in deceased donor renal transplant recipients: a randomized, controlled, phase IIB trial. Transplantation 100, 176-183. doi: 10.1097/TP.0000000000000770
169. Tolosano, E., and Altruda, F. (2002). Hemopexin: structure, function, and regulation. DNA Cell Biol. 21, 297-306. doi: 10.1089/104454902753759717
170. Tolosano, E., Fagoonee, S., Hirsch, E., Berger, F. G., Baumann, H., Silengo, L., et al. (2002). Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood 100, 4201-4208. doi: 10.1182/blood-2002-04-1270
171. Tolosano, E., Fagoonee, S., Morello, N., Vinchi, F., and Fiorito, V. (2010). Heme scavenging and the other facets of hemopexin. Antioxid. Redox Signal. 12, 305-320. doi: 10.1089/ars.2009.2787
172. Tolosano, E., Hirsch, E., Patrucco, E., Camaschella, C., Navone, R., Silengo, L., et al. (1999). Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. Blood 94, 3906-3914
173. Tracz, M. J., Alam, J., and Nath, K. A. (2007). Physiology and pathophysiology of heme: implications for kidney disease. J. Am. Soc. Nephrol. 18, 414-420. doi: 10.1681/ASN.2006080894
174. Trakshel, G. M., Kutty, R. K., and Maines, M. D. (1986). Purification and characterization of the major constitutive form of testicular heme oxygenase. The noninducible isoform. J. Biol. Chem. 261, 11131-11137
175. True, A. L., Olive, M., Boehm, M., San, H., Westrick, R. J., Raghavachari, N., et al. (2007). Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ. Res. 101, 893-901. doi: 10.1161/CIRCRESAHA.107.158998
176. Tzima, S., Victoratos, P., Kranidioti, K., Alexiou, M., and Kollias, G. (2009). Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-β production. J. Exp. Med. 206, 1167-1179. doi: 10.1084/jem.20081582
177. Vercellotti, G. M., Zhang, P., Nguyen, J., Abdulla, F., Chen, C., Nguyen, P., et al. (2016). Hepatic overexpression of hemopexin inhibits inflammation and vascular stasis in murine models of sickle cell disease. Mol. Med. 22, 437-451. doi: 10.2119/molmed.2016.00063
178. Vincent, S. H. (1989). Oxidative effects of heme and porphyrins on proteins and lipids. Semin. Hematol. 26, 105-113
179. Vincent, S. H., Grady, R. W., Shaklai, N., Snider, J. M., and Muller-Eberhard, U. (1988). The influence of heme-binding proteins in heme-catalyzed oxidations. Arch. Biochem. Biophys. 265, 539-550. doi: 10.1016/0003-9861(88)90159-2
180. Vincent, S. H., and Muller Eberhard, U. (1985). A protein of the Z class of liver cytosolic proteins in the rat that preferentially binds heme. J. Biol. Chem. 260, 14521-14528
181. Vinchi, F., De Franceschi, L., Ghigo, A., Townes, T., Cimino, J., Silengo, L., et al. (2013). Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases. Circulation 127, 1317-1329. doi: 10.1161/CIRCULATIONAHA.112.130179
182. Vinchi, F., Gastaldi, S., Silengo, L., Altruda, F., and Tolosano, E. (2008). Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am. J. Pathol. 173, 289-299. doi: 10.2353/ajpath.2008.071130
183. Vinchi, F., Costa da Silva, M., Ingoglia, G., Petrillo, S., Brinkman, N., Zuercher, A., et al. (2016). Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease. Blood 127, 473-486. doi: 10.1182/blood-2015-08-663245
184. Wagener, E., Feldman, T., de Witte, T., and Abraham, N. G. (1997). Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc. Soc. Exp. Biol. Med. 216, 456-463. doi: 10.3181/00379727-216-44197
185. Wagener, F. A., Eggert, A., Boerman, O. C., Oyen, W. J., Verhofstad, A., Abraham, N. G., et al. (2001). Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98, 1802-1811. doi: 10.1182/blood.V98.6.1802
186. Wagener, F. A., Volk, H. D., Willis, D., Abraham, N. G., Soares, M. P., Adema, G. J., et al. (2003). Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 55, 551-571. doi: 10.1124/pr.55.3.5
187. Wang, D., Cortes-Puch, I., Sun, J., Solomon, S. B., Kanias, T., Remy, K. E., et al. (2012a). Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia. Transfusion 54, 1712-1724. doi: 10.1111/trf.12607
188. Wang, D., Sun, J., Solomon, S. B., Klein, H. G., and Natanson, C. (2012b). Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 52, 1184-1195. doi: 10.1111/j.1537-2995.2011.03466.x
189. Warren, H. S., Tompkins, R. G., Moldawer, L. L., Seok, J., Xu, W., Mindrinos, M. N., et al. (2015). Mice are not men. Proc. Natl. Acad. Sci. U.S.A. 112:E345. doi: 10.1073/pnas.1414857111
190. Wei, Q., Hill, W. D., Su, Y., Huang, S., and Dong, Z. (2011). Heme oxygenase-1 induction contributes to renoprotection by G-CSF during rhabdomyolysis-associated acute kidney injury. Am. J. Physiol. Renal Physiol. 301, F162-F170. doi: 10.1152/ajprenal.00438.2010
191. Wijayanti, N., Katz, N., and Immenschuh, S. (2004). Biology of heme in health and disease. Curr. Med. Chem. 11, 981-986. doi: 10.2174/0929867043455521
192. Wijayanti, N., Kietzmann, T., and Immenschuh, S. (2005). Heme oxygenase-1 gene activation by the NAD(P)H oxidase inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride via a protein kinase B, p38-dependent signaling pathway in monocytes. J. Biol. Chem. 280, 21820-21829. doi: 10.1074/jbc.M502943200
193. Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., et al. (1999). Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103, 129-135. doi: 10.1172/JCI4165
194. Yamada, N., Yamaya, M., Okinaga, S., Nakayama, K., Sekizawa, K., Shibahara, S., et al. (2000). Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66, 187-195. doi: 10.1086/302729
195. Yuan, X., Rietzschel, N., Kwon, H., Walter Nuno, A. B., Hanna, D. A., Phillips, J. D., et al. (2016). Regulation of intracellular heme trafficking revealed by subcellular reporters. Proc. Natl. Acad. Sci. U.S.A. 113, E5144-E5152. doi: 10.1073/pnas.1609865113
196. Zarjou, A., Bolisetty, S., Joseph, R., Traylor, A., Apostolov, E. O., Arosio, P., et al. (2013). Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. J. Clin. Invest. 123, 4423-4434. doi: 10.1172/JCI67867
197. Zhong, H., Bao, W., Friedman, D., and Yazdanbakhsh, K. (2014). Hemin controls T cell polarization in sickle cell alloimmunization. J. Immunol. 193, 102-110. doi: 10.4049/jimmunol.1400105